Insight Molecular Diagnostics Inc.

By person

27 insiders · 126 transactions

0.2×

Joshua Riggs holds only 0.2 times base salary in stock. $139.61K of shares against $472.29K in salary for 2025.

Salary from the company's own proxy. The shares are what Joshua Riggs last reported holding, valued at $3.64, the price Common Stock, no par value was last bought or sold at on the open market here, on 27 Apr 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BROADWOOD PARTNERS, L.P. entity

10% owner

$70.71M (46)

—

+$70.71M

56,862,456

—

$206.93M

—

ANDREWS RONALD ASBURY

Former CEO

$42.97M (7)

—

+$42.97M

583,212

1.78%

$2.12M

—

Lineage Cell Therapeutics, Inc. entity

Previous 10% Owner

—

$16.28M (3)

−$16.28M

6,041,154

18.46%

$21.98M

−58.8%

PURA VIDA INVESTMENTS, LLC entity

10% owner

$8.09M (9)

$102.63K (4)

+$7.99M

8,090,202

24.72%

$29.44M

+47.5%

SMITH PATRICK W

10% owner

$2.45M (9)

—

+$2.45M

3,258,485

9.96%

$11.86M

+93.5%

Arno Andrew

Director

$479.98K (9)

—

+$479.98K

312,869

0.9561%

$1.14M

—

James Andrea S.

Chief Financial Officer

$345.80K (3)

—

+$345.80K

206,060

0.6297%

$749.87K

—

Levine Mitchell S

Chief Financial Officer

$62.41K (4)

—

+$62.41K

87,080

0.2661%

$316.89K

—

Gutfreund John Peter

Former Director

$47.98K (2)

—

+$47.98K

715,000

2.18%

$2.60M

−64.0%

Redmond Cavan M.

Director

$47.56K (2)

—

+$47.56K

120,863

0.3693%

$439.83K

—

Kalajian Tony T

Sr.VP/Chief Accounting Officer

$26.33K (2)

—

+$26.33K

15,000

0.0458%

$54.59K

—

Ross Douglas T.

Former CSO

$21.00K (1)

—

+$21.00K

234,114

0.7154%

$851.96K

—

Paulsen Gisela

Former President and COO

$19.77K (1)

—

+$19.77K

366,500

1.12%

$1.33M

—

Last Andrew J.

Director

$17.40K (2)

—

+$17.40K

58,752

0.1795%

$213.80K

—

Riggs Josh

CEO and President

$10.00K (1)

—

+$10.00K

38,365

0.1172%

$139.61K

+33,261%

GRIFFITH MELINDA

Director

$10.00K (1)

—

+$10.00K

30,000

0.0917%

$109.17K

—

Carter Jennifer L.

Director

$9.98K (1)

—

+$9.98K

30,500

0.0932%

$110.99K

—

Yu Li

VP Cntrllr/Prncpl Acctng Offcr

—

$9.27K (1) scheduled

−$9.27K

16,872

0.0516%

$61.40K

—

KINGSLEY ALFRED D

Director

$23.27K (4)

$15.37K (4) scheduled

+$7.90K

601,990

1.84%

$2.19M

+46.9%

Parker Albert P

COO

$6.65K (1)

—

+$6.65K

10,586

0.0323%

$38.52K

—

ANNETT WILLIAM

President and CEO

— (1)

—

$0.00

3,500

0.0107%

$12.74K

—

HESTERBERG LYNDAL K.

CSO

— (1)

—

$0.00

7,477

0.0228%

$27.21K

—

BAILEY DON M

Director

—

247,001

0.7548%

$898.86K

0.0%

John Anish M.

Chief Financial Officer

—

150,000

0.4584%

$545.87K

—

SILVERMAN LOU

Director

—

55,807

0.1705%

$203.09K

—

Sundar Padmavathi

Chief Commercial Officer

—

4,177

0.0128%

$15.20K

—

Liu James Yang

VP ACCT, Cntlr, Treasurer, PAO

—

3,711

0.0113%

$13.50K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

BROADWOOD PARTNERS, L.P.

23 Sep 2021

10% owner

Exercised, kept

573,461

$3.15

$1.81M

Last Andrew J.

11 Jun 2021

Director

Exercised, kept

6,993

$3.00

$20.98K

KINGSLEY ALFRED D

28 Dec 2020

Director

Exercised, kept

65,271

$1.34

$87.46K

BROADWOOD PARTNERS, L.P.

21 Jul 2017

10% owner

Exercised, kept indirect

$3.25

$0.00

BROADWOOD PARTNERS, L.P.

21 Jul 2017

10% owner

Exercised, kept

540,000

$3.25

$1.76M

BROADWOOD PARTNERS, L.P.

17 Feb 2017

10% owner

Exercised, kept indirect

$3.25

$0.00

BROADWOOD PARTNERS, L.P.

17 Feb 2017

10% owner

Exercised, kept

425,000

$3.25

$1.38M

Show all 126 transactions →

Insight Molecular Diagnostics Inc.

By person

Individual transactions

What was left out